CIK 0000744218 · Large accelerated filer
Celldex Therapeutics, Inc.
Sign in to watch- Ticker
- CLDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133191702
- Phone
- 908-200-7500
- Business address
- 53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
- Former names
- AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-30 | Cavanaugh Sarah SVP OF CORP AFFAIRS & ADMIN. | Option exercise · Incentive Stock Option (Right to Buy) | −10,103 | 0 | ||
| 2024-05-30 | Crowley Elizabeth SR. VP & CPDO | Option exercise | +34,445 | $2.78 | $96K | 39,171 |
| 2024-05-30 | Crowley Elizabeth SR. VP & CPDO | Option exercise | +8,500 | $9.02 | $77K | 47,671 |
| 2024-05-30 | Crowley Elizabeth SR. VP & CPDO | Sale | −38,597 | $33.64 | $1.3M | 9,074 |
| 2024-05-30 | Crowley Elizabeth SR. VP & CPDO | Option exercise · Incentive Stock Option (Right to Buy) | −34,445 | 0 | ||
| 2024-05-30 | Crowley Elizabeth SR. VP & CPDO | Option exercise · Incentive Stock Option (Right to Buy) | −8,500 | 7,500 | ||
| 2024-02-13 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Option exercise | +4,166 | $9.02 | $38K | 5,924 |
| 2024-02-13 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Option exercise | +20,000 | $2.78 | $56K | 25,924 |
| 2024-02-13 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Option exercise · Incentive Stock Option (Right to Buy) | −4,166 | 0 | ||
| 2024-02-13 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Option exercise · Incentive Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2024-01-02 | Martin Samuel Bates SVP AND CFO | Option exercise | +10,750 | $2.78 | $30K | 35,128 |
| 2024-01-02 | Martin Samuel Bates SVP AND CFO | Option exercise · Incentive Stock Option (Right to Buy) | −10,750 | 0 | ||
| 2023-06-15 | Young Diane C. SVP, CHIEF MEDICAL OFFICER | Grant or award · Incentive Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2023-06-15 | Wright Richard M. SR. VP & CCO | Grant or award · Incentive Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2023-06-15 | PEPIN RONALD SR. VP & CBO | Grant or award · Incentive Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2023-06-15 | Martin Samuel Bates SVP AND CFO | Grant or award · Incentive Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2023-06-15 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Grant or award · Incentive Stock Option (right to buy) | +74,000 | 74,000 | ||
| 2023-06-15 | Heath-Chiozzi Margo SVP OF REGULATORY AFFAIRS | Grant or award · Incentive Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2023-06-15 | Crowley Elizabeth SR. VP &CPDO | Grant or award · Incentive Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2023-06-15 | Cavanaugh Sarah SVP OF CORP AFFAIRS & ADMIN. | Grant or award · Incentive Stock Option (right to buy) | +75,000 | 75,000 |
Page 7 of 10 · 182 trades